While Botox may still be the household name for the neuromodulator market, new entries threaten to seize some of its market shares, and for a good reason. RT002 is set to be a game-changer according to preliminary findings during clinical trials.

RT002’s competitors boast results that last approximately 3 months, while RT002 is on track to deliver six months of noticeable results consistently. Once this injectable hits the market, it is expected that patients will receive similar results to other neurotoxins at half the amount of those treatments. Can you imagine? The makers of RT002 did!

This neurotoxin is currently intended for aesthetic and therapeutic use, including glabellar lines and crow’s feet. Approval for medical use, such as treating migraines, is also being sought.

Results using this new, advanced neurotoxin are currently being assessed. Continue reading for promising information.
The average cost of this new, advanced neurotoxin is currently being assessed.
There is currently no anticipated downtime.
Individual results are anticipated to vary.
The information on this page has been reviewed for medical accuracy by
Dr. Allen Silanee, MD, FACOG
Allen Silanee, MD, is board-certified in obstetrics and gynecology (OBGYN) in Florida. Dr. Silanee has more than 18 years of experience in the obstetrics and gynecology field. Dr. Silanee is an expert in women’s health, specializing in general women’s OBGYN care and sexual wellness, as well as minimally invasive gynecology surgery, including robotic-assisted procedures.
 Rt002 History

History of RT002

RT002 represents the fifth entry into the neuromodulator market. As such, it shares its roots with Botox. FDA approval for the use of botulinum toxin was granted to Allergan, the creators of Botox, in 2002. While most people are familiar with the aesthetic uses, there are also many medical possibilities identified more recently.

Fast forward to now, Revance Therapeutics, a fairly new biotechnology company from Silicon Valley has arrived. Revance has developed a unique proprietary stabilizing excipient peptide technology that allows them to differentiate their products from others. Pending FDA approval, RT002 is considered to be an investigational product as it is still going through clinical trials. Initial findings have shown promise as a versatile long-lasting treatment for both aesthetic and medical purposes. Exact capabilities will be learned upon the conclusion of trials and being released into the market.

 Rt002 Beneftis

RT002 Benefits

It’s important to know that this injectable is not yet on the market. However, the main benefit of RT002 is in line with similar neurotoxins that help prevent the facial muscles from contracting, thereby minimizing or preventing wrinkles.

Reported benefits specific to RT002 include:

  • Potentially longer-lasting results
  • Potentially cheaper than other neurotoxins
  • Potentially safer
  • No animal or human-derived materials

Additional study is needed post-release to determine the full scope of benefits that RT002 will provide in your quest for redefining how aging looks and feels on you.

Happy Consumer

I’m looking so forward to when RT002 is available as an alternative to Botox and longer lasting!

Jazmyne A.
RT002 Q&A

Getting Started with RT002

Finding an expert to help you choose the right neurotoxin currently available is as simple as visiting our online community. At AgeEnvy, valuable information detailing neurotoxin treatments, as well as qualified providers for this treatment, is at your fingertips. Keep in mind that your health and safety comes first with any treatment. That’s why our mission is to give consumers control over their health by getting them connected with providers that are licensed, verified experts focused on cosmetic neurotoxin procedures.

Possible RT002 Side Effects

Possible treatment side effects include:

  • Headache
  • Eyelid Ptosis
  • Injection-related edema
  • Pain at the injection site

It’s important to remember that common side effects associated with other neurotoxins may be present. At this point, it’s too soon to determine the full range of side effects for RT002.

FAQS About RT002

Here you will find answers to our user’s most common questions. Our goal is to keep you easily informed as you research ways to realize your age management potential. If you have a question that isn’t answered here, please ask a doctor.

Find a Provider
How much does RT002 cost?

RT002 has not hit the market so an exact price range has not been established. Your geographic location along with your chosen practitioner will help determine the final cost. However, the price should be on par with the other options. It is important to note that Jeuveau, which is releasing soon is about 25% cheaper than Botox so it’s reasonable to assume RT002 will be in the middle of these two.

How many RT002 treatments will I need?

You will need the same amount of initial treatments as with any other neurotoxin. However, the results are anticipated to last longer so the total number will be fewer in the long run.

How long is the recovery time with RT002?

The treatment is non-invasive and patients have responded well to treatment so recovery time should be minimal if at all. For those who experience side effects, they may want to schedule additional rest time depending on their comfort level.

How quickly will I see results from RT002?

The results of RT002 are on track to be potentially noticed faster than its competitors. However, until all clinical studies are completed, the data can’t be relied on 100%. At the very least, the results will be on par with the other neurotoxins.

How long will my RT002 results last?

Initial findings during trials have shown that RT002 should provide six months worth of results. Keep in mind that this is subject to change until the findings are complete.

Are there other similar options to RT002?

Yes there are. To date, there are four other neurotoxins that all boast similar results available for patient use. They are Botox, Dysport, Xeomin, and Jeuveau. As of right now, RT002 is unavailable.